Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07433660 · ClinicalTrials.gov registry record
WellSpan-THRIVE Cancer QOL Study
A clinical trial of Cancer - Ovarian and Cancer (With or Without Metastasis), sponsored by WellSpan Health.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 5
- Study locations
NCT07433660 is a study of Cancer - Ovarian and Cancer (With or Without Metastasis) that is actively recruiting participants, run by WellSpan Health. The registered enrollment target is 1,000 participants, above the 113-participant average among 4 other Cancer - Ovarian trials with a reported enrollment target (785% higher). The trial reports 5 study locations across 1 state.
The verdict
NCT07433660, a study of Cancer - Ovarian and Cancer (With or Without Metastasis), is actively recruiting participants, sponsored by WellSpan Health.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 5
- Study locations
Study Summary
Cancer affects millions of people worldwide and can significantly impact not only survival, but also day-to-day quality of life. Treatments such as surgery, chemotherapy, and radiation can cause side effects like fatigue, pain, and neuropathy, which may affect physical function, emotional well-being, and social relationships. While many studies have examined factors that influence quality of life; such as age, type and stage of cancer, and treatment-related symptoms; there is still a need for tools that more fully reflect patients' lived experiences. This study aims to develop and implement a patient-centered quality of life (QOL) survey designed specifically for individuals with cancer. By directly involving patients in sharing what matters most to them, the survey seeks to provide a more complete and accurate understanding of how cancer and its treatment affect daily life. The results will help patients, families, and healthcare providers better identify needs, guide supportive care, and improve overall well-being throughout the cancer journey.
Conditions Studied
Study Locations (5)
Pennsylvania
- WellSpan Medical Oncology & Hematology - Chambersburg
- WellSpan Ephrata Cancer Center - Ephrata
- WellSpan Adams Cancer Center - Gettysburg
- WellSpan Sechler Family Cancer Center - Lebanon
- WellSpan York Cancer Center - York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2026-02 |
| Est. Completion | 2031-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07433660
The ClinicalTrials.gov registry entry for NCT07433660 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 113-participant average among 4 other Cancer - Ovarian trials with a reported enrollment target (785% higher). The listed sponsor is WellSpan Health, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Cancer - Ovarian appearing as the primary indexed condition, and to 0 interventions.
NCT07433660 reports 5 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07433660 about?
NCT07433660 is a clinical study titled "WellSpan-THRIVE Cancer QOL Study". Cancer affects millions of people worldwide and can significantly impact not only survival, but also day-to-day quality of life. Treatments such as surgery, chemotherapy, and radiation can cause side effects like fatigue, pain, and neuropathy, which may affect physical function, emotional well-being...
What is the current status of trial NCT07433660?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2026-02. Estimated completion is 2031-12.
What conditions does trial NCT07433660 study?
This clinical trial studies the following conditions: Cancer - Ovarian, Cancer (With or Without Metastasis), Cancer (Solid Tumors), Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative, Cancer Abdomen.
Who is sponsoring clinical trial NCT07433660?
This trial is sponsored by WellSpan Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07433660 being conducted?
This trial has 5 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer - Ovarian
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.